These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

811 related items for PubMed ID: 15036808

  • 1. Huntingtin-protein interactions and the pathogenesis of Huntington's disease.
    Li SH, Li XJ.
    Trends Genet; 2004 Mar; 20(3):146-54. PubMed ID: 15036808
    [Abstract] [Full Text] [Related]

  • 2. Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington's disease.
    Truant R, Atwal RS, Burtnik A.
    Prog Neurobiol; 2007 Nov; 83(4):211-27. PubMed ID: 17240517
    [Abstract] [Full Text] [Related]

  • 3. Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin.
    Bao J, Sharp AH, Wagster MV, Becher M, Schilling G, Ross CA, Dawson VL, Dawson TM.
    Proc Natl Acad Sci U S A; 1996 May 14; 93(10):5037-42. PubMed ID: 8643525
    [Abstract] [Full Text] [Related]

  • 4. Molecular aspects of Huntington's disease.
    Walling HW, Baldassare JJ, Westfall TC.
    J Neurosci Res; 1998 Nov 01; 54(3):301-8. PubMed ID: 9819135
    [Abstract] [Full Text] [Related]

  • 5. Hypothesis: Huntingtin may function in membrane association and vesicular trafficking.
    Truant R, Atwal R, Burtnik A.
    Biochem Cell Biol; 2006 Dec 01; 84(6):912-7. PubMed ID: 17215878
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease?
    Squitieri F, Frati L, Ciarmiello A, Lastoria S, Quarrell O.
    Mech Ageing Dev; 2006 Feb 01; 127(2):208-12. PubMed ID: 16274727
    [Abstract] [Full Text] [Related]

  • 10. Huntington's disease: seeing the pathogenic process through a genetic lens.
    Gusella JF, MacDonald ME.
    Trends Biochem Sci; 2006 Sep 01; 31(9):533-40. PubMed ID: 16829072
    [Abstract] [Full Text] [Related]

  • 11. PGC-1alpha, a new therapeutic target in Huntington's disease?
    McGill JK, Beal MF.
    Cell; 2006 Nov 03; 127(3):465-8. PubMed ID: 17081970
    [Abstract] [Full Text] [Related]

  • 12. Huntington's disease: how does huntingtin, an anti-apoptotic protein, become toxic?
    Rangone H, Humbert S, Saudou F.
    Pathol Biol (Paris); 2004 Jul 03; 52(6):338-42. PubMed ID: 15261377
    [Abstract] [Full Text] [Related]

  • 13. Huntington's disease: From molecular basis to therapeutic advances.
    Krobitsch S, Kazantsev AG.
    Int J Biochem Cell Biol; 2011 Jan 03; 43(1):20-4. PubMed ID: 21056115
    [Abstract] [Full Text] [Related]

  • 14. The channel hypothesis of Huntington's disease.
    Kagan BL, Hirakura Y, Azimov R, Azimova R.
    Brain Res Bull; 2011 Jan 03; 56(3-4):281-4. PubMed ID: 11719262
    [Abstract] [Full Text] [Related]

  • 15. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease.
    Weiss A, Klein C, Woodman B, Sathasivam K, Bibel M, Régulier E, Bates GP, Paganetti P.
    J Neurochem; 2008 Feb 03; 104(3):846-58. PubMed ID: 17986219
    [Abstract] [Full Text] [Related]

  • 16. Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model.
    Nguyen T, Hamby A, Massa SM.
    Proc Natl Acad Sci U S A; 2005 Aug 16; 102(33):11840-5. PubMed ID: 16087879
    [Abstract] [Full Text] [Related]

  • 17. Huntington's Disease: Mechanisms of Pathogenesis and Therapeutic Strategies.
    Jimenez-Sanchez M, Licitra F, Underwood BR, Rubinsztein DC.
    Cold Spring Harb Perspect Med; 2017 Jul 05; 7(7):. PubMed ID: 27940602
    [Abstract] [Full Text] [Related]

  • 18. Huntington's disease: a synaptopathy?
    Li JY, Plomann M, Brundin P.
    Trends Mol Med; 2003 Oct 05; 9(10):414-20. PubMed ID: 14557053
    [Abstract] [Full Text] [Related]

  • 19. Huntington's disease: from pathology and genetics to potential therapies.
    Imarisio S, Carmichael J, Korolchuk V, Chen CW, Saiki S, Rose C, Krishna G, Davies JE, Ttofi E, Underwood BR, Rubinsztein DC.
    Biochem J; 2008 Jun 01; 412(2):191-209. PubMed ID: 18466116
    [Abstract] [Full Text] [Related]

  • 20. Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies.
    Borrell-Pagès M, Zala D, Humbert S, Saudou F.
    Cell Mol Life Sci; 2006 Nov 01; 63(22):2642-60. PubMed ID: 17041811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.